荃信生物-B(02509)11月10日斥资299.83万港元回购15.64万股
Qyuns TherapeuticsQyuns Therapeutics(HK:02509) 智通财经网·2025-11-10 13:30

Core Viewpoint - The company, Zhenxin Biotechnology-B (02509), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Categories Company Actions - The company will spend HKD 2.9983 million to repurchase 156,400 shares [1] - The buyback price per share ranges from HKD 18.42 to HKD 19.84 [1]

荃信生物-B(02509)11月10日斥资299.83万港元回购15.64万股 - Reportify